New Orleans’ French Quarter gets its first-ever marijuana dispensary. ‘I’m speechless.’
A cannabis dispensary opens on Bourbon Street, marking the first medical dispensary in the French Quarter. NOLA Cannabis Co. offers free telehealth consultations with a fast turnaround, a flower bar, …
Cannabis sector hits 10-year milestone ahead of repeal vote
Massachusetts’ $10 billion cannabis market faces a November ballot question on repeal while the industry grapples with oversaturation and falling prices.
As repeal question looms, Massachusetts cannabis industry clears $10B
The legal cannabis industry, now a decade old, is an “integral part” of Massachusetts’ economy, a top state regulator has said.
Cannabis sector hits sales milestone ahead of repeal vote
Ten years after voters legalized recreational marijuana in Massachusetts, the adult-use cannabis industry here has topped $10 billion in gross sales, a milestone that comes as the industry faces …
Visa, Mastercard Likely Won’t Change Cannabis-Payment Policies Under Schedule III, GAO Finds
Unless cannabis is federally legalized, the industry’s obstacles with banking, loans and other basic financial services will persist, according to a federal report.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Curaleaf’s hostile takeover bid for Aurora is just the tip of the iceberg for cannabis consolidation. These 2 stocks could be the biggest winners
After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.
5 Best Cannabis ETFs for 2026 and How to Invest
Discover the best marijuana ETFs to invest in, offering diversified exposure to the cannabis industry with growth potential and reduced risk.
Why Rescheduling Might Not Move Canopy Growth’s Stock as Much as You Think
Canopy Growth is a marijuana stock, but U.S. regulations aren’t the main driver of its business.
Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So.
Be careful before bucking the bearish trend.
CbdMD Enters Definitive Agreement To Acquire Twinlab Brands To Expand Wellness Platform; Stock Up
(YCBD), a consumer wellness company, announced that it has entered into a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab, including Twinlab, Reserveage, …
Black Tie CBD Introduces Expert-Curated BudTender’s Choice THCA Flower Program
BROWNS SUMMIT, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) — Black Tie CBD today introduced its new BudTender’s Choice program, combining Certified Ganjier recommendations with flexible subscription options …
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo’s Optimized …
Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses …
Will NYSE Composite Cannabis Stocks Extend Gains After CBD Shift?
Cannabis sector developments and NYSE Composite discussions intensified after federal CBD enforcement changes, highlighting hemp-derived products, wellness markets, and evolving regulatory frameworks.
TLRY stock back into the limelight – a look at the key developments that sparked investor optimism
The DEA rescheduling hearing that could reclassify marijuana is expected to be held on June 29. ・On Thursday, the Trump Administration pushed Congress to keep hemp CBD products legal by amending the …
Recent Comments